Conference Description:

The 2nd IPF Summit is the IPF industry definitive discussion and networking forum, helping drug developers to solve the translational gap between limited preclinical predictability and corresponding clinical attrition.

Built with Boehringer Ingelheim, Bristol Myers Squibb and Celgene, this intimate summit will pre-competitively advance the field beyond empirical data and more confidently translate IPF candidates through drug development pipelines.

URLs:
Tickets: https://go.evvnt.com/221385-1?pid=154
Brochure: https://go.evvnt.com/221385-2?pid=154

Time: 8:50 am to 5:00 pm

Prices:
Early Bird by May 18: USD 2499.0,
Early Bird by June 15: USD 2599.0,
Early Bird by July 13: USD 2699.0,
Standard Price: USD 2799.0

Speakers: Gerald Nabozny (Boehringer Ingelheim), Joe Arron (Genentech), Fernando Martinez (Weill Cornell Medical College), Timothy Blackwell (Vanderbilt University Medical Center), Jan De Backer (FLUIDDA)